SynGenSys
PrivateLast Round
Seed
Apr 1, 2025
Total Funding Raised
$4.09M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SynGenSys is a biotechnology company that designs synthetic gene promoter systems to address bottlenecks in biopharma manufacturing and enhance cell and gene therapy development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SynGenSys Comparables
Compare SynGenSys with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chromatin Bioscience | 92% | |
| Concinnity Genetics | 82% | |
| Annogen | 81% |
SynGenSys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 1, 2025 | ||||
| Seed | Apr 3, 2024 |
SynGenSys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UKRI Innovate UK | Seed |
| Takeda Ventures | Seed |
| The University of Sheffield | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 106% MoM, reaching 3.1K.
- Jul 20, 2026
Open roles increased to 5, 2.1x the trailing average.
Recent news
Latest coverage and updates
- hiresSep 18, 2026
Syngensys Ltd hires Abayomi Johnson as Head of Cell and Gene Therapy Expression Technologies.
- hiresSep 18, 2026
Syngensys Ltd hired Thilo Pohle as Head of Commercial on Jul 22nd '26.
- launchesAug 13, 2026
Syngensys Ltd launched CHO.SET 2.0 at Biotech Week Boston on Aug 13th '26.
SynGenSys Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SynGenSys's valuation, stock price, and market status.
Is SynGenSys a public or private company?
SynGenSys is a private company.
What is the current stock price of SynGenSys?
SynGenSys is a private company with no public stock price. No recent secondary market data is available.
How much is SynGenSys worth (valuation)?
Valuation information for SynGenSys is not publicly available.
Can I buy SynGenSys stock?
SynGenSys shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SynGenSys's last funding round?
SynGenSys's most recent funding round was Seed on April 1, 2025.
Who are the main investors in SynGenSys?
Key investors in SynGenSys include UKRI Innovate UK, Takeda Ventures, The University of Sheffield.
Will SynGenSys IPO soon?
No public IPO plans have been announced for SynGenSys.
How can I track SynGenSys secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SynGenSys's secondary market activity and sign up for updates.